Why the study?
Are peripheral autonomous potentials altered in patients with primary and drug-induced headaches compared to healthy subjects and those with low back pain?
Are peripheral autonomous potentials altered in patients with primary and drug-induced headaches compared to healthy subjects and those with low back pain?
Sympathetic hypofunction, as measured by increased PAP latencies, appears to be a general phenomenon in headache disorders and is exacerbated by drug abuse.
No takes yet. Share an insight, caveat, or question.
Sympathetic hypofunction may mark headache disorders broadly; hypothesis-generating for PAPs as biomarkers pending prospective studies.
Evers et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: